What diagnostic tests should be ordered for a patient with bilateral axillary lymphadenopathy and arm pain to evaluate for infectious, inflammatory, neoplastic, vascular, or musculoskeletal etiologies?

Diagnostic Testing for Bilateral Axillary Lymphadenopathy with Arm Pain

Order bilateral axillary ultrasound as the initial imaging test, followed by diagnostic mammography (or digital breast tomosynthesis) to evaluate for an underlying breast primary, and obtain basic laboratory studies including complete blood count, inflammatory markers (ESR/CRP), and consider tuberculosis testing based on risk factors. 1

Initial Imaging Approach

Primary Test: Bilateral Axillary Ultrasound

Axillary ultrasound is the most appropriate first-line imaging modality for bilateral axillary lymphadenopathy 1. The ACR Appropriateness Criteria (2022) specifically addresses this clinical scenario and establishes ultrasound as the standard initial test.

Ultrasound can:

• Differentiate solid from cystic masses
• Characterize lymph node morphology (size, shape, cortical thickness, presence of fatty hilum)
• Identify normal variants (accessory breast tissue, ectopic breast tissue)
• Guide biopsy if suspicious features are present
• Distinguish between benign reactive adenopathy and concerning features 1

The differential for bilateral axillary lymphadenopathy is broad, including:

• Infectious/inflammatory: Reactive adenopathy from systemic infections, mastitis, granulomatous disease
• Neoplastic: Lymphoma, leukemia, metastatic breast cancer
• Benign: Lipomas, normal variants, lactational changes 1

Complementary Breast Imaging

Add diagnostic mammography and/or digital breast tomosynthesis (DBT) to evaluate for an underlying breast primary that could explain the lymphadenopathy 1. The NCCN guidelines specifically recommend this combination approach when patients present with axillary lymphadenopathy, as it provides global breast assessment and can identify occult breast malignancies or associated findings like microcalcifications 1.

Laboratory Studies

Based on general medicine principles for lymphadenopathy evaluation 2, 3:

Order the following initial labs:

• Complete blood count with differential (evaluate for leukemia, lymphoma, infection)
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to assess for inflammatory/infectious processes
• Tuberculosis testing if risk factors present (travel history, exposures, endemic areas)

Consider additional testing based on clinical context:

• Autoimmune serologies if systemic symptoms suggest rheumatologic disease
• Infectious disease workup if fever, night sweats, or specific exposures present
• Lactate dehydrogenase (LDH) if lymphoma suspected

When to Consider Advanced Imaging

CT Chest/Abdomen/Pelvis

Reserve CT for specific scenarios 1:

• When systemic disease or non-mammary malignancy (particularly lymphoma) is suspected
• To evaluate extent of disease if initial workup suggests malignancy
• To assess for other areas of lymphadenopathy
• To evaluate chest wall, bony, or intrathoracic involvement

Important caveat: CT is NOT appropriate as an initial test for bilateral axillary lymphadenopathy 1. The guidelines explicitly state insufficient evidence supports CT as first-line imaging.

FDG-PET/CT

Do not order PET/CT as initial imaging 1. While PET/CT can detect lymphadenopathy throughout the body, there is no evidence supporting its use as a first-line test for bilateral axillary adenopathy 1. It may be considered later if lymphoma or metastatic disease is confirmed and staging is needed.

Breast MRI

MRI is not routinely indicated initially 1. Consider MRI only if:

• Mammography/DBT is negative but suspicious lymphadenopathy persists
• Need to identify occult breast primary (MRI detects occult breast cancer in >66% of cases with adenopathy of unknown primary) 1
• Need to characterize extent of disease or vascular/chest wall involvement

Biopsy Considerations

Proceed to ultrasound-guided biopsy if:

• Lymph nodes demonstrate suspicious sonographic features (loss of fatty hilum, cortical thickening >3mm, round shape, abnormal vascularity)
• Lymphadenopathy persists beyond 4 weeks without clear benign explanation 2
• Nodes are >2 cm, hard, or matted/fused 2
• Patient has concerning systemic symptoms (fever, night sweats, unintentional weight loss)

Biopsy options (in order of preference for initial tissue diagnosis):

1. Ultrasound-guided core needle biopsy (preferred for adequate tissue architecture)
2. Fine-needle aspiration (can distinguish benign from malignant but may be limited for lymphoma subtyping)
3. Excisional biopsy if percutaneous methods non-diagnostic 3

Critical Pitfalls to Avoid

• Do not start corticosteroids empirically - they can mask histologic diagnosis of lymphoma or other malignancy 2, 3
• Do not skip breast imaging - even with bilateral adenopathy, breast cancer remains in the differential and requires evaluation 1
• Do not order PET/CT or CT as first-line tests - this wastes resources and exposes patients to unnecessary radiation without improving diagnostic accuracy 1
• Do not assume benign etiology without tissue diagnosis if nodes persist >4 weeks or have concerning features 2

Addressing the Arm Pain Component

While the guidelines focus on lymphadenopathy imaging, the arm pain warrants consideration of:

• Musculoskeletal causes: Consider plain radiographs of affected areas if trauma, overuse, or focal bone pain
• Vascular causes: Doppler ultrasound if vascular compromise suspected
• Nerve compression: Clinical examination for neurologic deficits; MRI if radiculopathy or plexopathy suspected

However, start with the lymphadenopathy workup first as outlined above, since enlarged nodes can cause local compression symptoms and pain. The arm pain may resolve once the underlying cause of lymphadenopathy is identified and treated.